Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 15;67(11):e0071423.
doi: 10.1128/aac.00714-23. Epub 2023 Oct 24.

The directed evolution of NDM-1

Affiliations

The directed evolution of NDM-1

Caitlyn A Thomas et al. Antimicrob Agents Chemother. .

Abstract

β-Lactam antibiotics are among the most frequently prescribed therapeutic agents. A common mechanism of resistance toward β-lactam antibiotics is the production of β-lactamases. These enzymes are capable of hydrolyzing the β-lactam bond, rendering the drug inactive. Among the four described classes, the metallo- β-lactamases (MBLs, class B) employ one or two zinc ions in the active site for catalysis. One of the three most clinically relevant MBLs is New Delhi Metallo- β-Lactamase (NDM-1). The current study sought to investigate the in vitro protein evolution of NDM-1 β-lactamase using error-prone polymerase chain reaction. Evaluation revealed that variants were not found to confer higher levels of resistance toward meropenem based on amino acid substitutions. Thus, we postulate that increases in transcription or changes in zinc transport may be clinically more relevant to meropenem resistance than amino acid substitutions.

Keywords: NDM-1; antibiotic resistance; antimicrobial resistance; beta-lactamases; beta-lactams; drug resistance evolution.

PubMed Disclaimer

Conflict of interest statement

Tthe authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Immunoblot for NDM-1 WT, NDM-9, and six mutants generated by error-prone PCR. The anti-NDM antibody used is derived from mouse serum.
Fig 2
Fig 2
Representations of the mutations made to wild-type NDM-1. (A) The wild-type NDM-1 structure was taken from PDB: 4EXY37. The gray spheres represent the two active site zinc ions. Active site residues coordinating the zinc ions are shown as white sticks. The T173S mutation (variant 3-9) is shown in cyan. The E152K mutation (variant 5-14) is shown in yellow. The magenta color for residue 42, the first residue present in the crystal structure, shows the location of the amino-terminus where the E2D mutation of mutant 5-14 would be located (the first ~40 amino acid residues are not present in crystal structures). (B) Close-up view of the E152K mutation shown with an AlphaFold model of NDM-1 E152K (dark gray) superimposed onto the wild-type NDM-1 structure (light gray). Active site zinc ions in the background are shown as spheres. Electrostatic interactions between Lys152 and Asp223 are shown as dashed lines (yellow) with labeled distances in Å. (C) Close-up view of the T173S mutation shown with an AlphaFold model of NDM-1 T173S (dark gray) superimposed onto the wild-type NDM-1 structure (light gray).

References

    1. Bahr G, González LJ, Vila AJ. 2021. Metallo-β-Lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design. Chem Rev 121:7957–8094. doi:10.1021/acs.chemrev.1c00138 - DOI - PMC - PubMed
    1. Wang X, Minasov G, Shoichet BK. 2002. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol 320:85–95. doi:10.1016/S0022-2836(02)00400-X - DOI - PubMed
    1. Cheng Z, Thomas PW, Ju L, Bergstrom A, Mason K, Clayton D, Miller C, Bethel CR, VanPelt J, Tierney DL, Page RC, Bonomo RA, Fast W, Crowder MW. 2018. Evolution of new Delhi Metallo-β-Lactamase (NDM) in the clinic: effects of NDM mutations on stability, zinc affinity, and mono-zinc activity. J Biol Chem 293:12606–12618. doi:10.1074/jbc.RA118.003835 - DOI - PMC - PubMed
    1. Cheng Z, Bethel CR, Thomas PW, Shurina BA, Alao J-P, Thomas CA, Yang K, Marshall SH, Zhang H, Sturgill AM, Kravats AN, Page RC, Fast W, Bonomo RA, Crowder MW. 2021. Carbapenem use is driving the evolution of Imipenemase 1 variants. Antimicrob Agents Chemother 65:1–19. doi:10.1128/AAC.01714-20 - DOI - PMC - PubMed
    1. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations.

Publication types

LinkOut - more resources